1. Phase 1 First‐in‐Human, Single‐ and Multiple‐Ascending Dose, and Food Effect Studies to Assess the Safety, Tolerability, and Pharmacokinetics of Presatovir for the Treatment of Respiratory Syncytial Virus Infection. (17th April 2018) Authors: German, Polina; Xin, Yan; Chien, Jason W.; Weng, Winnie; Mackman, Richard; Lewis, Sandra A.; Meng, Amy; Ling, John; Mathias, Anita Journal: Journal of clinical pharmacology Issue: Volume 58:Number 8(2018) Page Start: 1025 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗